Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.

Also called NCT01632371

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 252 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01632371
Other papers using this trial's data
  • Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial JACC. Cardiovascular interventions, 2017-07-10 DOI, PubMed 28683939

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01632371. Randomized; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4
Acronym
ISAR-DESIRE 4
Condition
Restenosis
Condition
Stable Angina Pectoris
Condition
Acute Coronary Syndrome
Intervention (Device)
Paclitaxel Eluting Balloon + Scoring Balloon
Intervention (Device)
Paclitaxel Eluting Balloon
Lead sponsor
Deutsches Herzzentrum Muenchen (class: other)
Collaborator
Biotronik AG (class: industry)

Record details

Record id
cardio:ct-nct01632371
Content hash
17fb233302350f2876a0d2e9d2af1727558c5a1aaf683aa5d5d69a31f64821e3